Literature DB >> 9247343

Nanos and pumilio establish embryonic polarity in Drosophila by promoting posterior deadenylation of hunchback mRNA.

C Wreden1, A C Verrotti, J A Schisa, M E Lieberfarb, S Strickland.   

Abstract

Nanos protein promotes abdominal structures in Drosophila embryos by repressing the translation of maternal hunchback mRNA in the posterior. To study the mechanism of nanos-mediated translational repression, we first examined the mechanism by which maternal hunchback mRNA is translationally activated. In the absence of nanos activity, the poly(A) tail of hunchback mRNA is elongated concomitant with its translation, suggesting that cytoplasmic polyadenylation directs activation. However, in the presence of nanos the length of the hunchback mRNA poly(A) tail is reduced. To determine if nanos activity represses translation by altering the polyadenylation state of hunchback mRNA, we injected various in vitro transcribed RNAs into Drosophila embryos and determined changes in polyadenylation. Nanos activity reduced the polyadenylation status of injected hunchback RNAs by accelerating their deadenylation. Pumilio activity, which is necessary to repress the translation of hunchback, is also needed to alter polyadenylation. An examination of translation indicates a strong correlation between poly(A) shortening and suppression of translation. These data indicate that nanos and pumilio determine posterior morphology by promoting the deadenylation of maternal hunchback mRNA, thereby repressing its translation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247343     DOI: 10.1242/dev.124.15.3015

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  87 in total

Review 1.  Cytoplasmic polyadenylation in development and beyond.

Authors:  J D Richter
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

2.  The 3' untranslated region of human vimentin mRNA interacts with protein complexes containing eEF-1gamma and HAX-1.

Authors:  May Al-Maghrebi; Hervé Brulé; Marina Padkina; Carrie Allen; W Michael Holmes; Zendra E Zehner
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

3.  Drosophila Brain Tumor is a translational repressor.

Authors:  J Sonoda; R P Wharton
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

4.  Identification of a conserved interface between PUF and CPEB proteins.

Authors:  Zachary T Campbell; Elena Menichelli; Kyle Friend; Joann Wu; Judith Kimble; James R Williamson; Marvin Wickens
Journal:  J Biol Chem       Date:  2012-04-11       Impact factor: 5.157

5.  Xenopus Nanos1 is required to prevent endoderm gene expression and apoptosis in primordial germ cells.

Authors:  Fangfang Lai; Amar Singh; Mary Lou King
Journal:  Development       Date:  2012-03-07       Impact factor: 6.868

6.  Drosophila Pumilio protein contains multiple autonomous repression domains that regulate mRNAs independently of Nanos and brain tumor.

Authors:  Chase A Weidmann; Aaron C Goldstrohm
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

Review 7.  Trading translation with RNA-binding proteins.

Authors:  Irina Abaza; Fátima Gebauer
Journal:  RNA       Date:  2008-01-22       Impact factor: 4.942

Review 8.  Nanos genes and their role in development and beyond.

Authors:  Evi De Keuckelaere; Paco Hulpiau; Yvan Saeys; Geert Berx; Frans van Roy
Journal:  Cell Mol Life Sci       Date:  2018-02-03       Impact factor: 9.261

Review 9.  RNA and sex determination in Caenorhabditis elegans. Post-transcriptional regulation of the sex-determining tra-2 and fem-3 mRNAs in the Caenorhabditis elegans hermaphrodite.

Authors:  A Puoti; P Pugnale; M Belfiore; A C Schläppi; Z Saudan
Journal:  EMBO Rep       Date:  2001-10       Impact factor: 8.807

10.  Recruitment of the Puf3 protein to its mRNA target for regulation of mRNA decay in yeast.

Authors:  John S Jackson; S Sean Houshmandi; Florencia Lopez Leban; Wendy M Olivas
Journal:  RNA       Date:  2004-08-30       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.